A detailed history of Werba Rubin Papier Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Werba Rubin Papier Wealth Management holds 508 shares of LLY stock, worth $388,472. This represents 0.11% of its overall portfolio holdings.

Number of Shares
508
Previous 395 28.61%
Holding current value
$388,472
Previous $358 Million 25.85%
% of portfolio
0.11%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $87,251 - $108,482
113 Added 28.61%
508 $450 Million
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $286,323 - $359,070
395 New
395 $358 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Werba Rubin Papier Wealth Management Portfolio

Follow Werba Rubin Papier Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Werba Rubin Papier Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Werba Rubin Papier Wealth Management with notifications on news.